Bumper Offer - Urjas oil Just @ Rs. 1
Moxicip, a prescription drug, is manufactured in various forms such as Tablet, Solution, Drops, Ointment, Infusion. Primarily, it is used for the treatment of Bacterial Infections. Moxicip also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Moxicip. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Moxicip are Nausea or vomiting, Diarrhoea. Some other side effects of Moxicip have been listed ahead. Usually, these side effects of Moxicip go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Moxicip's effect during pregnancy is Moderate and Severe while nursing. In addition, Moxicip's effects on the liver, heart and kidney are discussed below in the Moxicip related warnings section.
Moxicip can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Moxicip in conditions like Myasthenia Gravis (MG), Peripheral Neuropathy, Neuropathy, Peripheral. Other conditions have been mentioned below in the Moxicip contraindications section.
Drug reaction of Moxicip with other medicines has been reported. See below for a complete list.
You should also be aware that Moxicip is not safe while driving, and is not addiction.
Moxicip is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Moxicip is used -
Severe
Moderate
Mild
Common
Is the use of Moxicip safe for pregnant women?
Moxicip may have some side effects during pregnancy. Pregnant women should discontinue the use of Moxicip, and talk to their doctor, if they notice any discomfort.
Is the use of Moxicip safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Moxicip. So it is adviced to consult the doctor before using it.
What is the effect of Moxicip on the Kidneys?
Moxicip is not harmful for kidneys.
What is the effect of Moxicip on the Liver?
Moxicip is completely safe for the liver.
What is the effect of Moxicip on the Heart?
Very few cases of side effects of Moxicip on the heart have been reported.
Moxicip should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Mild
If you are suffering from any of the following diseases, you should not take Moxicip unless your doctor advises you to do so -
Is this Moxicip habit forming or addictive?
Forming a habit of Moxicip has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Moxicip can make you feel drowsy.
Is it safe?
Moxicip is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Moxicip cannot treat any kind of mental disorder.
Interaction between Food and Moxicip
Moxicip may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Moxicip
Taking Moxicip and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
